PlainRecalls
FDA Drug Moderate Class II Terminated

Nystatin Oral Suspension, USP 500,000 Units/5 mL, a). 50 unit dose cups of 5 mL per case (NDC No. 66689-037-50), b). 100 unit dose cups of 5 mL per case (NDC 66689-037-99), Rx only, Manufactured by VistaPharm, Largo, FL 33771.

Reported: February 8, 2017 Initiated: January 18, 2017 #D-0461-2017

Product Description

Nystatin Oral Suspension, USP 500,000 Units/5 mL, a). 50 unit dose cups of 5 mL per case (NDC No. 66689-037-50), b). 100 unit dose cups of 5 mL per case (NDC 66689-037-99), Rx only, Manufactured by VistaPharm, Largo, FL 33771.

Reason for Recall

CGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.

Details

Recalling Firm
VistaPharm, Inc.
Units Affected
55,191 unit dose cups
Distribution
Nationwide
Location
Largo, FL

Frequently Asked Questions

What product was recalled?
Nystatin Oral Suspension, USP 500,000 Units/5 mL, a). 50 unit dose cups of 5 mL per case (NDC No. 66689-037-50), b). 100 unit dose cups of 5 mL per case (NDC 66689-037-99), Rx only, Manufactured by VistaPharm, Largo, FL 33771.. Recalled by VistaPharm, Inc.. Units affected: 55,191 unit dose cups.
Why was this product recalled?
CGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 8, 2017. Severity: Moderate. Recall number: D-0461-2017.